5327772026-10-285327772026-10-282026-10-285327772026-10-282026-10-28UnitOrDivisionOrSubsidiaryDomain15327772026-10-28UnitOrDivisionOrSubsidiaryDomain1iso4217:INRxbrli:pure532777Info Edge (India) LimitedNAUKRINOTLISTEDINE663F01032NewSale or disposal of unit(s)/division(s)/subsidiarytrue2026-10-2813:45:002026-10-28OthersMedcords Healthcare Solutions Private Limited (‘Medcords’)000000002026-11-262027-01-27CashAbout Rs. 5000.The entire Shareholding of 14.18% on fully converted and diluted basis held by Company through its wholly-owned subsidiary Startup Investments (Holding) Limited (SIHL) will be sold to Mr. Shreyans Mehta, Director and Promoter of Medcords. Mr. Shreyans Mehta is Promoter and Director of Medcords. The buyer is not related to promoter/promoter group/group companies of the Company. falsefalsetruefalseA provision for impairment of full amount against investment in Medcords was booked in FY 2023-24. Accordingly, Medcords has not contributed to any of the relevant financial parameters, including Total Income, Net Worth, Turnover and Revenue, in the consolidated financial statements of the Company for FY 2025–26. Therefore, the amounts and corresponding percentages attributable to Medcords in respect of the aforesaid financial parameters for FY 2025–26 have been mentioned as Nil. The agreement for sale shall be entered into within 30 days from the Board’s approval. The transaction of sale/disposal/divestment of the Company’s stake held in Medcords on fully converted and diluted basis i.e. 14.18% through its wholly-owned subsidiary SIHL, has been approved by the Board of Directors of the Company in its meeting held today, i.e. on October 28, 2026. The Company will submit an update on the execution of Agreement for sale/disposal which is expected to be completed by January 27, 2027. Post this divestment, Medcords will cease to be Joint Venture of the Company. The said transaction does not qualify as a Related Party Transaction, accordingly, the arm’s length requirements is not applicable. However, for the purpose of validating the sheet, “Yes” has been selected in Column 26(F).